Abstract
Objective: To study the mechanism of action and therapeutic effect of modified Qiwei Baishu powder in diabetic patients. Methods: From January 2021 to January 2022, 80 diabetic patients were recruited in our study and divided into two groups by the random number table method. Group A was treated with modified Qiwei Baishu powder, whereas group B was treated with western medicine. The therapeutic effect, traditional Chinese medicine (TCM) syndrome score, blood sugar level, and incidence of adverse reaction were compared between the two groups. Result: The therapeutic effect in group A was significantly higher than that in group B (P < 0.05); the TCM syndrome scores of group A were significantly lower than those of group B (P < 0.05); the fasting blood glucose (FBG), 2 hour-postprandial blood glucose (PBG), and glycosylated hemoglobin (HbA1c) levels of group A were significantly lower than those of group B (P < 0.05); the incidence of adverse reaction in group A was significantly lower than that in group B (P < 0.05). Conclusion: On the basis of western medicine, the addition of modified Qiwei Baishu powder can maintain stable blood sugar levels in patients and alleviate diabetic symptoms; thus, it is not only effective, but also safe for clinical use in diabetes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
